Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Haug

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Pharmacy|September 1, 1982
Treatment of metabolic alkalosisM T Haug, S Traeger
Journal of Toxicology. Clinical Toxicology|January 1, 1986
Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver diseaseS M Traeger, M T Haug
Drug Intelligence & Clinical Pharmacy|September 1, 1982
Predictability of theophylline levelsS Melethil, J D Carlson, M T Haug
American Journal of Hospital Pharmacy|November 1, 1980
Use of digoxin serum assays in a nonteaching hospitalC W Greenlaw, G S Geiger, M T Haug
American Journal of Hospital Pharmacy|February 1, 1981
Prediction of digoxin blood levelsC W Greenlaw, M T Haug, G S Geiger
Archives of Internal Medicine|November 1, 1992
Ranitidine pharmacokinetics and adverse central nervous system reactionsP H Slugg, M T Haug, C E Pippenger
American Journal of Hospital Pharmacy|January 1, 1979
TPN formulationsC W Greenlaw, G S Geiger, M T Haug
DICP : the Annals of Pharmacotherapy|November 1, 1989
Effect of renal failure and hemodialysis on aminocaproic acid plasma concentrationsM T Haug, V F Mauro, H H Davis
Contributions to Nephrology|January 1, 1991
Comparative vancomycin kinetics in intensive care unit patients with acute renal failure: intermittent hemodialysis versus continuous hemofiltration hemodialysisP H Slugg, M T Haug, C Bosworth, et al.
Clinical Pharmacy|September 1, 1984
Extended verapamil infusion for recurrent atrial tachyarrhythmias complicating acute myocardial infarctionM T Haug, J DeRespino, J Zimmerman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Pharmacy|September 1, 1982
Treatment of metabolic alkalosisM T Haug, S Traeger
Journal of Toxicology. Clinical Toxicology|January 1, 1986
Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver diseaseS M Traeger, M T Haug
Drug Intelligence & Clinical Pharmacy|September 1, 1982
Predictability of theophylline levelsS Melethil, J D Carlson, M T Haug
American Journal of Hospital Pharmacy|November 1, 1980
Use of digoxin serum assays in a nonteaching hospitalC W Greenlaw, G S Geiger, M T Haug
American Journal of Hospital Pharmacy|February 1, 1981
Prediction of digoxin blood levelsC W Greenlaw, M T Haug, G S Geiger
Archives of Internal Medicine|November 1, 1992
Ranitidine pharmacokinetics and adverse central nervous system reactionsP H Slugg, M T Haug, C E Pippenger
American Journal of Hospital Pharmacy|January 1, 1979
TPN formulationsC W Greenlaw, G S Geiger, M T Haug
DICP : the Annals of Pharmacotherapy|November 1, 1989
Effect of renal failure and hemodialysis on aminocaproic acid plasma concentrationsM T Haug, V F Mauro, H H Davis
Contributions to Nephrology|January 1, 1991
Comparative vancomycin kinetics in intensive care unit patients with acute renal failure: intermittent hemodialysis versus continuous hemofiltration hemodialysisP H Slugg, M T Haug, C Bosworth, et al.
Clinical Pharmacy|September 1, 1984
Extended verapamil infusion for recurrent atrial tachyarrhythmias complicating acute myocardial infarctionM T Haug, J DeRespino, J Zimmerman, et al.
Pageof 3